I see this as a strategic business plan.
Australian study is being done in Queensland.
Realistically how many extra would be enrolled per week?
I believe this delay in releasing the Australian blind data is a positive move by RAP.
LUV RAP
MB
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides Update on Australian Clinical Study
Ann: ResApp Provides Update on Australian Clinical Study, page-19
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)